As of Feb. 5, 2026, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.Here's the latest list of major overbought players in this sector.Almonty Industries Inc (NASDAQ:ALM)On Feb. 4, DA Davidson analyst Griffin Bryan maintained Almonty Industries with a Buy and raised the price target from $12 to $18. The company's stock gained around 39% over the past month and has a 52-week high of $13.82.RSI Value: 74.1          ...

We recently published 10 Stocks Crushing Wall Street With Massive Gains. Almonty Industries Inc. (NASDAQ:ALM) was one of the top performers on Tuesday. Almonty Industries soared to a new all-time high on Tuesday, as investors loaded portfolios in rare earth and mining stocks following news that more than 50 minerals are expected to be included in President Donald Trump’s inventory program. At intra-day trading, the stock soared to its highest price of $13.60 before paring gains to finish the session jus ...

Core Viewpoint - Almonty Industries Inc. shares have experienced a significant rally, attributed to increased trading volume and positive developments regarding its mining projects [1][2]. Group 1: Stock Performance - Almonty Industries Inc. shares rose by 9.1% to close at $12.11, with a notable trading volume exceeding typical levels [1]. - The stock has gained 24.9% over the past four weeks, indicating strong investor interest [1]. Group 2: Project Developments - The company is advancing towards full-scale commercial operation of Phase 1 at the Sangdong Tungsten Mine, expected in 2026, with Phase II expansion planned for 2027 [2]. - A large-scale drilling program at the Panasqueira Mine is set to define the mine plan for expansion into Level 4 in 2026 [3]. - The Sangdong Molybdenum Project is progressing towards reserve definition and development planning [3]. - Production readiness at the Gentung Browns Lake Project is anticipated by the second half of 2026 [3]. Group 3: Financial Expectations - Almonty Industries is expected to report a quarterly loss of $0.01 per share, unchanged from the previous year, with revenues projected at $12.41 million, reflecting a 176.3% increase year-over-year [4]. - The consensus EPS estimate for the upcoming quarter has remained stable over the last 30 days, suggesting that stock price movements may be influenced by earnings estimate trends [5]. Group 4: Industry Context - Almonty Industries Inc. holds a Zacks Rank of 3 (Hold), indicating a neutral outlook within the Zacks Mining - Miscellaneous industry [6]. - Materion, a peer in the same industry, has also maintained a Zacks Rank of 3, with a recent stock price increase of 0.4% [6][7].

Core Viewpoint - Almonty Industries Inc. has shown significant growth in its share prices, driven by a positive outlook for its tungsten business amid limited global supply [1] Company Developments - Almonty Industries plans to advance the Sangdong tungsten mine in South Korea towards full-scale phase 1 commercial operations, with a phase 2 expansion expected in 2027 [2] - Upon completion, the Sangdong mine is projected to produce 460,000 MTU annually, positioning it as one of the largest tungsten mines outside of China [3] Strategic Agreements - The company has secured binding hard floor offtake agreements, including long-term commitments to supply tungsten oxide for US defense applications, which enhances future revenue visibility and underscores the strategic value of its production [4]

Our achievements in 2025 significantly strengthened our operational foundation, expanded our global footprint, and enhanced our visibility in the capital markets. Sangdong Tungsten Mine – Active Mining Operations In December 2025, we marked the transition of our flagship Sangdong Tungsten Mine in South Korea from construction to production with the delivery of the first truckload of ore to the run-of-mine pad. That first truck load marked the start of active mining operations and the final phase before full ...

Core Viewpoint - Almonty Industries Inc. is experiencing significant stock performance due to the imminent start of commercial operations at its Sangdong Tungsten Mine in South Korea, which is crucial for diversifying the tungsten supply chain away from China [1][3]. Group 1: Company Developments - Almonty Industries' stock rose by 6.64% to close at $8.35 as investors anticipate the start of commercial operations at its mine [1]. - The company has successfully delivered its first truckload of ore to the Run-of-Mine pad at the Sangdong Tungsten Mine, marking a critical step before official commercial operations begin [2]. - The first ore placement is seen as a strategic inflection point for Almonty, aiming to strengthen the global tungsten supply chain and reduce reliance on China, which currently supplies over 80% of the world's tungsten [3]. Group 2: Strategic Importance - The resumption of production at the Sangdong Mine is essential for securing a reliable, non-China tungsten supply for key sectors, including defense, semiconductors, AI hardware, and aerospace [4]. - Almonty acquired the Sangdong mine after the US halted its mining operations in 2015 and has since focused on bringing the site back into production [4]. - Preparatory works such as geological assessments, ground stabilization, load testing, and equipment installation have been completed to advance the project [5].

Core Viewpoint - Investors are encouraged to consider shares of Almonty Industries Inc. (ALM), a NASDAQ-listed company, aligning with market sentiment and Wall Street perspectives [1] Company Overview - Almonty Industries Inc. is highlighted as a viable investment option for various types of investors, including those focused on dividends, value propositions, or growth opportunities [1]

Core Viewpoint - Almonty Industries has successfully delivered the first truckload of ore to the ROM pad at the Sangdong Mine, marking a significant transition to active mining operations and paving the way for commercial production [1][2]. Company Developments - The first ore placement at the Sangdong Mine is seen as a strategic inflection point for Almonty, aimed at strengthening the global tungsten supply chain and reducing reliance on China, which currently supplies over 80% of the world's tungsten [2][4]. - The ROM pad will serve as a staging area for ore, which will undergo primary and secondary crushing, grinding, and flotation to produce tungsten-bearing minerals for downstream customers [3][4]. - Preparatory work for the project has been completed, confirming that the ROM pad is operational and that the necessary equipment and workflows are functioning effectively [4]. Industry Context - The Sangdong Mine is positioned to play a critical role in diversifying tungsten supply for the U.S., European Union, and Korea, addressing supply vulnerabilities highlighted by recent geopolitical tensions [2][5]. - Upon reaching full capacity, the Sangdong Mine is expected to supply over 80% of global non-China tungsten production, which is essential for sectors such as defense, semiconductors, and aerospace [5]. - The development of the Sangdong Mine, along with an upcoming tungsten oxide plant and a planned molybdenum deposit, aims to establish a fully integrated strategic-mineral value chain, enhancing resource security for the U.S. and its allies [4][5].

Group 1 - The market for critical minerals has shifted from a basic commodity model to one focused on national security and supply chain reliability [1] - There is a growing emphasis on identifying companies with strong brand recognition, solid financials, and growth potential within the consumer products sector [1] - Understanding consumer trends is crucial for identifying profitable investment opportunities in the industry [1]

Group 1 - U.S. stocks experienced a decline, with the Nasdaq Composite dropping over 100 points on Monday [1] - Kyverna Therapeutics Inc shares surged 31% to $11.49 following the announcement of topline data from the KYSA-8 Phase 2 trial [2][3] - The KYSA-8 trial involved mivocabtagene autoleucel (miv-cel), a CAR T-cell therapy targeting stiff person syndrome [1] Group 2 - Other notable stock gains included Beneficient, which increased by 29.3% to $6.21, and Immunome Inc, which rose 25.5% to $24.56 after positive results from its Phase 3 trial [3] - Falcon's Beyond Global Inc gained 14% to $12.83, while XBP Global Holdings Inc surged 11.5% to $6.39 [3] - Almonty Industries Inc announced a voluntary withdrawal of its base shelf prospectus, leading to a 9.1% increase in its stock price to $7.38 [3]